From sailors to scale: The evolution of clinical trials.

At Praxis, we are hyper-focused on the “why” and the “how” of clinical research – and those answers are deeply rooted in history. After all, the clinical trial landscape didn’t emerge overnight; it’s the result of centuries of refinement, ethical shifts, and the occasional radical breakthrough. Let’s look back at some of the pivotal moments that shaped the industry.

1747: The first controlled trial.

Long before the double-blind study was the gold standard, James Lind, a physician in the British Royal Navy, was faced with a crisis: Scurvy was killing more sailors than enemy warfare. In 1747, Lind conducted what is widely recognized as the first authentic controlled clinical trial.

He selected 12 sailors with similar symptoms and divided them into six pairs. Each pair received a different treatment ranging from cider and vinegar to seawater and, crucially, citrus fruits. The results were undeniable; the sailors given oranges and lemons recovered within days. While simple by today’s standards, Lind’s use of comparative groups laid the foundation for evidence-based medicine.

1863: The power of the placebo.

Fast forward to the American Civil War era. US physician Austin Flint conducted the first recorded study comparing a placebo to an active treatment for rheumatism. This was a revolutionary shift in thinking. By introducing a placebo, Flint demonstrated that the human body often has an inherent ability to heal and that we needed to define what it means for a treatment to be considered truly “effective.”

1948: The birth of randomization.

The modern era of clinical research truly began in 1948 with the UK Medical Research Council’s (MRC’s) trial of streptomycin for tuberculosis. This was the first randomized controlled trial, or RCT. By randomly assigning patients to treatment groups, researchers could finally eliminate selection bias, ensuring that the results were due to the drug itself rather than the characteristics of the patients. This set the rigorous standard we still use today.

1962: The efficacy evolution.

This important history isn’t just confined to trials, it’s also about the laws that govern them. The 1962 Kefauver-Harris Amendment was a watershed moment for the FDA. It required drugs to be proven not just safe, but effective – and the law was retroactive.

This led to a massive re-evaluation of thousands of drugs. It produced blockbusters like Valium and led to the removal of drugs like Panalba, an antibiotic combination the FDA ruled as “irrational therapy.” This established a vital legal precedent that commercial success is not a substitute for clinical proof.

2020: Scalable success.

When the COVID-19 pandemic hit, the clinical trial industry faced its greatest challenge. How do you maintain the rigor established by Lind, Flint, and the MRC while moving at the speed of a global emergency?

We saw years of development compressed into months without sacrificing safety. By leveraging unprecedented scale, intentionally representative populations, and adaptive study designs, researchers delivered highly effective vaccines to the global community with record-breaking speed.

The Praxis takeaway.

The history of clinical trials is a journey from observation to innovation – from 12 sailors on a ship to thousands of global participants connected via telehealth, the goal of proving what works to save lives remains the same.

Ready to make history with your next trial? Let’s connect to build the future of clinical research together.